1. Home
  2. MTRX vs PRLD Comparison

MTRX vs PRLD Comparison

Compare MTRX & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$12.41

Market Cap

361.0M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$3.84

Market Cap

391.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRX
PRLD
Founded
1984
2016
Country
United States
United States
Employees
2239
N/A
Industry
Engineering & Construction
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.0M
391.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MTRX
PRLD
Price
$12.41
$3.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$17.00
$5.67
AVG Volume (30 Days)
204.5K
484.2K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
$769,286,000.00
$12,140,000.00
Revenue This Year
$19.75
$320.10
Revenue Next Year
$7.96
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
5.64
73.43
52 Week Low
$9.88
$0.75
52 Week High
$16.11
$5.69

Technical Indicators

Market Signals
Indicator
MTRX
PRLD
Relative Strength Index (RSI) 44.62 35.95
Support Level $11.79 $3.40
Resistance Level $12.62 $4.13
Average True Range (ATR) 0.44 0.32
MACD 0.01 -0.11
Stochastic Oscillator 42.16 3.85

Price Performance

Historical Comparison
MTRX
PRLD

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: